What is actually happening in Diabetes?

What's Happening with the Diabetes Crisis?

5.6 million people have diabetes in the UK — type 2 diagnoses rising 40% since 2010 — costing the NHS £10bn/year, with obesity the primary driver.

Diabetes is one of the fastest-growing long-term conditions in the UK. The number of people diagnosed has risen from around 3.3 million in 2010 to 5.6 million in 2024.[1] Add in the estimated 1 million with undiagnosed type 2 diabetes and a further 13.6 million at high risk of developing it, and the scale of the challenge becomes clear.[1] Type 2 diabetes accounts for 91% of cases and is almost entirely preventable — it is driven by obesity, physical inactivity, and dietary patterns that are themselves shaped by socioeconomic conditions.[2]

The NHS spends around £10bn per year on diabetes — approximately 10% of its entire budget.[3] Around 80% of that cost falls on managing complications: kidney failure, cardiovascular disease, lower limb amputations, and retinopathy.[3] The UK has a higher rate of diabetes-related lower limb amputations than most comparable countries, reflecting both delayed diagnosis and inconsistent access to specialist foot care.[2] Diabetes also drives a substantial share of NHS kidney disease, dialysis, and stroke workload.

Deprivation is a major factor. Type 2 diabetes prevalence is two to three times higher in the most deprived communities compared to the least deprived.[1] South Asian, Black African, and Black Caribbean populations face significantly higher risk at lower BMI thresholds than white European populations — a difference that is not consistently reflected in clinical guidance or screening thresholds.[2]

Diabetes prevalence in UK 2010–2024 (millions, type 1 vs type 2)

Diagnosed diabetes cases. Type 2 has risen 76% since 2010, driven primarily by obesity. An estimated 1 million more people have undiagnosed diabetes.

Type 1 diabetes (millions)
Type 2 diabetes (millions)

Source: Diabetes UK / NHS Digital, Diabetes prevalence — diagnosed cases by type, 2024, Updated annual

NHS diabetes expenditure 2010–2024 (£bn)

Total NHS spending on diabetes treatment, including hospital admissions, medications, and complications. Represents around 10% of total NHS England budget.

Source: NHS England, NHS diabetes expenditure and programme costs, 2024, Updated annual

What is showing promise

NHS Diabetes Prevention Programme2016–present

The NHS Diabetes Prevention Programme (NHS DPP), the world's largest structured diabetes prevention programme, has enrolled over 1.5 million people since 2016. Participants at high risk of type 2 diabetes are referred to a 9-month lifestyle programme combining dietary advice, physical activity, and behaviour change. NHSE evaluation shows a 26% reduction in type 2 diabetes incidence in completers. New GLP-1 receptor agonist drugs (semaglutide), approved for weight management in 2023, offer an additional pharmacological route to prevention at scale — though NHS supply constraints limit current access.

Source: NHS England — Diabetes Prevention Programme 2024; NICE — Semaglutide appraisal 2023; Diabetes UK statistics 2024.

  1. [1]Diabetes UKStatistics, 2024
  2. [2]NHS DigitalNational Diabetes Audit, 2024
  3. [3]NHS EnglandDiabetes — expenditure and prevention programme data, 2024

Sources & Methodology

Diabetes UK — Statistics — prevalence estimates by type. Annual. Retrieved 2024.

NHS Digital — National Diabetes Audit — care processes and outcomes. Annual. Retrieved 2024.

NHS England — Diabetes — expenditure and prevention programme data. Annual. Retrieved 2024.

Prevalence figures are for diagnosed diabetes in the UK. Undiagnosed diabetes is estimated separately. NHS cost figures include all NHS-attributed diabetes spending including complications. All figures are for the UK unless otherwise stated.

More in NHS & Healthcare